AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AZN Key Statistics
AZN News
AstraZeneca's (AZN) stock is up following its latest earnings report Thursday after the company reported $12.7 billion in revenue, beating consensus estimates o...
It has been a busy week for pharma giants reporting their latest quarterly earnings and a lot of them have exceeded analysts’ estimates. HGTV's Property Brot...
AstraZeneca shares (AZN) revealed a first-quarter earnings beat on Thursday, posting revenue of $12.68 billion, a 19% year-over-year gain. In addition, the phar...
Analyst ratings
73%
of 30 ratingsMore AZN News
↗️ **AstraZeneca (UK: AZN**, **AZN**): The pharmaceutical giant posted a better-than-expected jump in revenue in the first quarter, while earnings also topped e...
In this article: AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance Thursday, AstraZeneca Plc (NASDAQ:AZN) reporte...
AstraZeneca (NASDAQ:AZN) ADRs rose sharply higher in the premarket Thursday after the British drugmaker topped Street forecasts with its Q1 2024 results thanks...
In this article: AstraZeneca soundly topped analyst views while Sanofi narrowed its losses. Both stocks surged in early trade....
AstraZeneca (AZN) has released an update. AstraZeneca PLC reported strong financial performance for the first quarter of 2024, with a 19% increase in Total Rev...
AstraZeneca (NASDAQ:AZN) shares are on the rise today after the biopharmaceutical major reported robust numbers for the first quarter. Revenue jumped by 19% yea...
AstraZeneca Plc shares surged after the UK drugmaker reported profit that outpaced expectations, buoyed by demand for its cancer blockbusters Imfinzi and Tagris...
